What is HHS's earnings growth forecast for 2025-2025?
(NASDAQ: HHS) Harte Hanks's forecast annual earnings growth rate of N/A is not forecast to beat the US Conglomerates industry's average forecast earnings growth rate of N/A, and while it is not forecast to beat the US market's average forecast earnings growth rate of N/A.
Harte Hanks's earnings in 2025 is -$5,447,000.
In 2025, HHS is forecast to generate $8,013,168 in earnings, with the lowest earnings forecast at $7,775,153 and the highest earnings forecast at $8,330,521.
What is HHS's revenue growth forecast for 2025-2025?
(NASDAQ: HHS) Harte Hanks's forecast annual revenue growth rate of N/A is not forecast to beat the US Conglomerates industry's average forecast revenue growth rate of N/A, and while it is not forecast to beat the US market's average forecast revenue growth rate of N/A.
Harte Hanks's revenue in 2025 is $166,841,000.
In 2025, HHS is forecast to generate $1,463,309,596 in revenue, with the lowest revenue forecast at $1,419,858,903 and the highest revenue forecast at $1,521,293,285.
What is HHS's forecast return on assets (ROA) for 2025-2025?
(NASDAQ: HHS) forecast ROA is 8.64%, which is lower than the forecast US Conglomerates industry average of 9.52%.
What is HHS's Earnings Per Share (EPS) forecast for 2025-2025?
(NASDAQ: HHS) Harte Hanks's current Earnings Per Share (EPS) is -$0.73. In 2025, HHS's EPS is forecast to hit $1.08 (min: $1.05, max: $1.12).
What is HHS's forecast return on equity (ROE) for 2025-2025?
(NASDAQ: HHS) forecast ROE is 40.31%, which is considered strong.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.